Open Veterinary Journal, published by the University of Tripoli, Faculty of Veterinary Medicine, offers a vital platform for the dissemination of research in the field of veterinary sciences. With an ISSN of 2226-4485 and an E-ISSN of 2218-6050, this journal has been committed to open access since 2011, allowing for unfettered access to its content, which ensures that researchers, practitioners, and students worldwide can benefit from the latest veterinary research findings. Operating from Libya, it has garnered an important position within the academic community, achieving a Q2 quartile ranking in the scope of veterinary (miscellaneous) and maintaining a Scopus rank of 104 out of 194 within the general veterinary category, indicating its growing influence and reach. The journal focuses on a diverse array of topics pertinent to contemporary veterinary practice, aiming to bridge gaps in knowledge and foster collaboration among scholars and practitioners. As it continues to publish original research and reviews, Open Veterinary Journal stands as a crucial resource for advancing veterinary medicine, supporting innovative research, and enhancing educational outcomes within the profession.

Exposure and Health is a pioneering journal published by Springer, specializing in the interdisciplinary fields of health, toxicology, and environmental sciences. With an ISSN of 2451-9766 and E-ISSN of 2451-9685, this open-access journal exemplifies a commitment to disseminating high-quality research that informs public health practices and policies globally. Situated in the Netherlands, it boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple categories in the 2023 Scopus rankings, including Health, Toxicology and Mutagenesis, Pollution, and Water Science and Technology. The journal is dedicated to advancing knowledge on the interactions between environmental factors and health outcomes, making it a vital resource for researchers, professionals, and students in these critical fields. Exposure and Health actively encourages submissions that address the challenges of exposure assessment, risk management, and the promotion of sustainable public health initiatives.

Toxicology Research is a distinguished journal dedicated to advancing the field of toxicology through the dissemination of high-quality research. Published by Oxford University Press, this UK-based journal focuses on critical aspects of toxicology and mutagenesis, highlighting both environmental and pharmacological implications. With an ISSN of 2045-452X and an E-ISSN of 2045-4538, it serves as a valuable resource for researchers, professionals, and students alike. Currently categorized in the Q3 quartile for Health, Toxicology and Mutagenesis, as well as Toxicology in 2023, Toxicology Research maintains a visible presence in Scopus rankings, positioning itself within the targeted professional community. Although the journal operates without open access options, its importance in contributing to scientific discussions and policy formation is undeniable. Covering content from 2012 to 2024, it continues to provide insights into contemporary toxicological challenges, thereby fostering interdisciplinary collaborations and informing best practices in health and safety.

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.

CELL BIOLOGY AND TOXICOLOGY, published by SPRINGER, stands as a vital journal within the realms of cell biology and toxicology, boasting an impressive 2023 Q1 ranking in its fields, alongside robust Scopus rankings placing it in the top 11th percentile for Toxicology and the 22nd for Health, Toxicology and Mutagenesis. With an ISSN of 0742-2091 and an E-ISSN of 1573-6822, the journal has been a cornerstone of scientific discourse since its inception in 1984, and will continue to converge innovative research until 2024. The journal focuses on the interplay between cellular mechanisms and toxicological implications, making it an essential resource for researchers, healthcare professionals, and students keen on advancing their understanding of these critical areas. Although it does not offer open access, its high impact and prestigious standing ensure that its publications reach a wide audience dedicated to significant advancements in the life sciences.

Current Drug Safety is a distinguished peer-reviewed journal published by Bentham Science Publishers, focusing on the critical intersection of pharmacology and toxicology. With an ISSN of 1574-8863 and an E-ISSN of 2212-3911, this journal serves as a platform for the latest research and advances in drug safety, highlighting the importance of pharmacological assessments and toxicity evaluations in therapeutic development and public health. Reaching a broad international audience from its base in the United Arab Emirates, Current Drug Safety offers an invaluable resource for researchers, professionals, and students interested in the dynamic fields of drug research and safety management. Despite a current Q3 categorization in multiple pharmacology and toxicology quartiles for 2023, the journal continues to strive for excellence in the scholarly community, reflecting its commitment to disseminating high-quality research. While not operating under an open access model, articles can be accessed through institutional subscriptions and other platforms, ensuring valuable insights into drug safety are available to those who need it most.

Toxicologie Analytique et Clinique is a distinguished journal published by ELSEVIER MASSON SAS EDITEUR, specializing in the ever-evolving fields of toxicology and clinical analysis. With its ISSN number 2352-0078 and E-ISSN 2352-0086, this journal has been contributing to the scientific dialogue since its inception in 2014, with a converged publication timeline extending to 2024. Despite its current standing in the Q4 category for both Health, Toxicology and Mutagenesis, and Toxicology in the 2023 metrics, as indicated by its rankings on Scopus, Toxicologie Analytique et Clinique remains a crucial platform for disseminating vital research within these domains. The journal's focus on analytical and clinical toxicology makes it an invaluable resource for researchers, practitioners, and students, seeking to enhance their understanding and methodologies in toxicological studies. As a vital contributor to the academic landscape, Toxicologie Analytique et Clinique aims to provide a rich repository of knowledge that promotes innovation and safety in clinical practices and environmental science.

Kuwait Medical Journal is a prominent scholarly publication dedicated to advancing medical knowledge and practice in the Gulf region and beyond. Published by the Kuwait Medical Association, this journal has been a crucial platform for disseminating research findings since its inception in 1973. Despite its discontinuation in Scopus coverage after 1990, it remains significant within the Q4 category in Medicine (miscellaneous), serving as a valuable resource for healthcare professionals, researchers, and students alike. The journal is based in Kuwait and aims to foster academic dialogue by featuring original research articles, reviews, and case studies that highlight the evolving landscape of medical science and practice. While currently not an open-access platform, the Kuwait Medical Journal continues to uphold the integrity and quality of medical research, contributing to the broader discourse in healthcare.

Welcome to the Italian Journal of Medicine, a distinguished publication in the realm of medical research and practice, diligently published by PAGEPRESS PUBL since 2007. This journal serves as a vital platform for the dissemination of innovative research findings, clinical studies, and reviews, providing an essential resource for researchers, healthcare professionals, and medical students alike. With an ISSN of 1877-9344 and an E-ISSN of 1877-9352, the journal embraces an Open Access model, ensuring that knowledge is accessible to all and promoting collaboration across the global medical community. While it currently holds a Q4 ranking in the miscellaneous category of medicine and a respectable rank of #372 out of 636 in General Medicine according to Scopus metrics, the Italian Journal of Medicine remains committed to improving its impact and reach in the scientific landscape. Situated in Pavia, Italy, the journal aims to bridge the gap between research and practice, fostering advancements that ultimately enhance patient care.

TOXICOLOGICAL SCIENCES, published by Oxford University Press, is a premier journal in the field of toxicology that has been a cornerstone of scientific discourse since its inception in 1981. With an impressive 2023 impact factor and ranked in the Q1 category for Toxicology, this journal is highly regarded among researchers, professionals, and students dedicated to pharmacology and toxicology. The journal is committed to advancing the understanding of toxicological science, covering a breadth of topics that include the mechanisms of toxicity, risk assessment, and the regulatory aspects affecting public health. With an ISSN of 1096-6080 and an E-ISSN of 1096-0929, TOXICOLOGICAL SCIENCES facilitates open access scholarly work, ensuring that critical research reaches a global audience and promotes collaborative learning. As it converges towards 2024, the journal remains pivotal in shaping the future of toxicology research, providing insights that are essential for developing safer chemicals and protecting environmental health.